(*) CA Approval Date: 2020. 08.13.
(*) USA Approval Date: 2019. 05.24.
>Endocrine-based regimen
Companion Diagnostics>
Company
Kinase Inhibitor
Patent(*)>Assignee; Claims; No.; Et
Patent>Total USA No.: 3
Patent>UpDate: 2019. 12.31.
TradeMark
TradeMark Web-Site